Gold criteria

Reading File
Reading File
Finding Sources
Searching PubMed

COPD AND GOLD

Searching the Web

GOLD 2026 COPD diagnosis spirometry FEV1 FVC classification ABE official report

GOLD criteria for COPD

1. Diagnosis

COPD is confirmed by post-bronchodilator spirometry showing:
[ \boxed{\text{FEV}_1/\text{FVC} < 0.70} ]
This should be interpreted in a person with compatible symptoms or exposures, such as chronic dyspnea, cough/sputum, smoking, biomass-fuel exposure, occupational dust/fumes, or recurrent respiratory infections. The GOLD 2026 report retains the fixed post-bronchodilator ratio of <0.70 for diagnosis.

2. Spirometric severity of airflow obstruction

Use post-bronchodilator FEV₁ % predicted once COPD is confirmed:
GOLD gradeFEV₁ % predictedSeverity
GOLD 1≥80%Mild
GOLD 250-79%Moderate
GOLD 330-49%Severe
GOLD 4<30%Very severe

3. Initial clinical assessment: GOLD ABE groups

GOLD now uses A, B, and E groups to guide initial treatment, based on symptoms plus prior exacerbations.
GroupSymptomsExacerbation history in previous year
ALow: CAT <10 or mMRC 0-10-1 moderate exacerbation, with no hospitalization
BMore: CAT ≥10 or mMRC ≥20-1 moderate exacerbation, with no hospitalization
EAny symptom level≥2 moderate exacerbations or ≥1 exacerbation requiring hospitalization
Definitions
  • CAT: COPD Assessment Test, score 0-40
  • mMRC: Modified Medical Research Council dyspnea scale
  • A moderate exacerbation generally requires oral corticosteroids and/or antibiotics; a severe one requires emergency care or hospitalization.
So a complete GOLD description might read:
“COPD confirmed by post-bronchodilator FEV₁/FVC <0.70; spirometric grade GOLD 3; Group E due to prior hospitalized exacerbation.”
The older ABCD grouping has been replaced by ABE, because high exacerbation risk is now grouped as E irrespective of symptom burden. See the official GOLD 2026 pocket guide.
This is a shared conversation. Sign in to Orris to start your own chat.